Understanding how C. difficile bacteria use RNA polymerase to survive and resist antibiotics
Mechanistic Dissection and Antibiotic Discovery Targeting Clostridioides difficile RNA Polymerase
This study is looking at how a harmful gut bacteria called Clostridioides difficile works and how it resists antibiotics, with the goal of finding new ways to create better treatments for people who get infections from it.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ut Southwestern Medical Center NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project ID | NIH-11080120 on NIH RePORTER |
What this research studies
This research focuses on Clostridioides difficile, a harmful gut bacteria that has become resistant to many antibiotics. The project aims to explore the mechanisms of RNA polymerase, a key enzyme involved in gene expression, and how it is regulated by specific transcription factors. By conducting biochemical, structural, and genetic studies, the researchers hope to uncover new strategies for developing effective antibiotics against this dangerous pathogen. Patients may benefit from insights that could lead to new treatments for C. difficile infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients suffering from C. difficile infections, particularly those who have not responded to standard antibiotic treatments.
Not a fit: Patients with infections caused by other types of bacteria or those who do not have C. difficile infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antibiotics that effectively target antibiotic-resistant C. difficile infections.
How similar studies have performed: Previous research has shown promise in targeting RNA polymerase in other bacterial pathogens, indicating that this approach may yield successful outcomes.
Where this research is happening
Dallas, United States
- Ut Southwestern Medical Center — Dallas, United States (Active)
Researchers
- Principal investigator: Cao, Xinyun — Ut Southwestern Medical Center
- Study coordinator: Cao, Xinyun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.